IRCT20220409054463N1尚未招募1 期
Evaluation of using metformin on ki-67 tumor marker gene expression in endometrial cancer patients referred to Imam Hossein and Mahdie hospital, beween 1401-1402
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 no limit（—）
- 性别
- Female
入选标准
- •All women with endometrial carcinoma pathology, regardless of age and histological stage, who have referred to Mahdieh / Imam Hossein (AS) Medical Center between 1401-1402 and are on the list of staging surgery of this center.
排除标准
- •Diabetes or the use of metformin or other blood sugar control drugs
- •Liver or kidney dysfunction
- •Simultaneous cancers over the last 5 years
- •Use of chemotherapy drugs or hormone therapy during the last 3 months
- •Any allergy to Biguanides or contraindications to the use of this class of drugs
研究者
相似试验
已完成
不适用
Comparison of the Effectiveness Metformin for Deceasing Proliferative Marker in Endometrial Cancer CellsMetforminCA EndometriumNCT03618472Rajavithi Hospital50
终止
3 期
MK0767 and Metformin Combination Study (0767-028)Diabetes MellitusNCT00543738Merck Sharp & Dohme LLC114
尚未招募
2 期
Metformin in the prevention of preeclampsiaPre-eclampsiapreeclampsia.IRCT20230730058975N1Esfahan University of Medical Sciences160
已完成
3 期
Effect of Metformin in Acne VulgarisAcne.Acne, unspecifiedL70.9IRCT20201108049309N1Shiraz University of Medical Sciences40
招募中
2 期
Study of effect of metformin in patients with relapsed epithelial ovarian cancerCTRI/2015/12/006454Cancer Institute WIA25